• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO CORPORATION, ASHITAKA CAPIOX FX25 HOLLOW FIBER OXYGENATOR AF; OXYGENATOR, CARDIOPULMONARY BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO CORPORATION, ASHITAKA CAPIOX FX25 HOLLOW FIBER OXYGENATOR AF; OXYGENATOR, CARDIOPULMONARY BYPASS Back to Search Results
Catalog Number 1CX*FX25W
Medical Device Problem Code Leak/Splash (1354)
Health Effect - Clinical Code No Consequences Or Impact To Patient (2199)
Date of Event 06/14/2016
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
The actual device has been returned to the manufacturing facility and the evaluation is currently ongoing.A follow up report will be submitted when the investigation is complete, but no later than 30 days from the date that this report was sent.For this reason code 11 was used in the conclusions section of h6.A review of the device history record and product release decision control sheets of the involved product/lot# combination was conducted with no relevant findings.A search of the complaint file found no report with the involved product code/lot# combination.Terumo medical products (tmp) (importer) registration no.2243441 is submitting this report on behalf of ashitaka factory of terumo corporation (manufacturer) registration no.9681834.Exemption number e2015022.All available information has been placed on file in quality assurance at the manufacturing facility for appropriate tracking, trending and follow-up.H3 other text : device is currently under evaluation.
 
Event or Problem Description
The user facility reported a leak in the fx25 capiox device pre cardiopulmonary bypass.Follow up communication with the user facility confirmed the following information: the product was changed out; the surgery was completed successfully; and there was no impact to the patient.
 
Additional Manufacturer Narrative
This report is being submitted as follow up # 1 to provide the returned sample evaluation results.Visual inspection upon receipt revealed no anomalies in the appearance.The blood pathway was filled with saline solution and pressure of 2.0kgf/cm2 was applied to the inside of the oxygenator module.No leak was observed.The investigation results verified that the actual sample was the normal product and there is no evidence that this event was related to a device defect or malfunction.With very limited information about the occurrence of the reported event, the cause of this complaint cannot be definitively determined.All available information has been placed on file in quality management for appropriate tracking, trending and follow up.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CAPIOX FX25 HOLLOW FIBER OXYGENATOR AF
Common Device Name
OXYGENATOR, CARDIOPULMONARY BYPASS
Manufacturer (Section D)
TERUMO CORPORATION, ASHITAKA
150 maimaigi-cho
fujinomiya city, shizuoka 418
JA  418
MDR Report Key5774757
Report Number9681834-2016-00166
Device Sequence Number18967666
Product Code DTZ
UDI-Device Identifier04987350701084
UDI-Public04987350701084
Combination Product (Y/N)N
Initial Reporter StateWV
Initial Reporter CountryUS
PMA/510(K) Number
K071494
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 07/07/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date12/31/2018
Device Catalogue Number1CX*FX25W
Device Lot Number160108
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer06/27/2016
Type of Report(Section G)FDA Requested
Initial Date Received by Manufacturer 06/14/2016
Supplement Date Received by ManufacturerNot provided
Initial Report FDA Received Date07/07/2016
Supplement Report FDA Received Date07/22/2016
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
-
-